FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
Anu Suomalainen(University of Helsinki), Henna Tyynismaa(University of Helsinki), Jan Smeıtınk(Radboud University Nijmegen), Pirjo Isohanni(University of Helsinki), Jana Buzková(University of Helsinki), Katrin Õunap(Tartu University Hospital), Hannele Yki‐Järvinen(University of Helsinki), Laurence A. Bindoff(Haukeland University Hospital), Anna H. Hakonen(University of Helsinki), M. Tulinius(University of Gothenburg), Kirsi H. Pietiläinen(University of Helsinki), Johanna Uusimaa(Oulu University Hospital), Helena Pihko(Helsinki University Hospital), Niklas Darín(University of Gothenburg), Sari Kiuru‐Enari(Helsinki University Hospital), Leo A. J. Kluijtmans(Radboud University Nijmegen), Ksenia Sevastianova(University of Helsinki), Sanna Marjavaara(University of Helsinki), Mari Korpela(Helsinki University Hospital), Johanna Annunen‐Rasila(Oulu University Hospital), Aila Rissanen, Michio Hirano(Columbia University Irving Medical Center), Anders Paetau(Helsinki University Hospital), Tiina Tyni(University of Helsinki), Jenni M. Elo(University of Helsinki)
Cited by 420
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k